U.S. market Closed. Opens in 2 days 1 hour 3 minutes

SURF | Surface Oncology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue30.00M2.69M126.16M15.36M59.42M12.83M6.63M
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A
Gross Profit30.00M2.69M126.16M15.36M59.42MN/AN/A
Operating Expenses91.87M78.70M64.58M72.73M68.57M58.82MN/A
Selling, General & Admin24.87M25.13M23.56M20.61M16.08M11.03M4.14M
Research & Development67.00M53.57M41.02M52.12M52.49M47.78M20.49M
Other Operating Expenses1.43M74.00KN/A2.58M2.55MN/AN/A
Operating Income-61.87M-76.01M61.59M-57.37M-9.15M-45.99M-18.00M
Other Expenses / Income-1.72M-2.47M-2.25M2.58M2.55M613.00K551.00K
Before Tax Income-63.59M-78.48M59.34M-54.79M-6.60M-45.38M-17.45M
Income Tax Expenses1.72M977.00K579.00K-1.78M2.55MN/AN/A
Net Income-65.30M-79.46M59.34M-53.00M-6.60M-45.38M-17.45M
Interest Expenses1.72M2.47M2.25MN/AN/AN/AN/A
Basic Shares Outstanding55.76M44.24M38.14M27.85M19.99M19.34M19.34M
Diluted Shares Outstanding55.76M44.24M38.14M27.85M19.99M19.34M19.34M
EBITDA-61.87M-76.01M61.59M-57.37M-9.15M-44.41M-17.12M
EBITDA Margin-206.23%-2,828.92%48.82%-373.48%-15.40%-346.27%-258.17%
EBIT-61.87M-76.01M62.16M-54.79M-4.04M-45.38M-17.45M
EBIT Margin-206.23%-2,828.92%49.27%-356.70%-6.80%-353.79%-263.16%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙